Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HERBERT G MARKLEY

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1043251598
CMS profile
273519
Location
WORCESTER, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$46,239.13

200 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 4 of 4; records 151–200 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HERBERT G MARKLEY

NPI 1043251598 · CMS profile ID 273519

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

WORCESTER, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–200 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043251598?year=2019&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HERBERT G MARKLEY, NPI 1043251598, CMS profile ID 273519. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–200 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043251598?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). HERBERT G MARKLEY, NPI 1043251598, CMS profile ID 273519. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–200 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043251598?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
HERBERT G MARKLEY, NPI 1043251598, CMS profile ID 273519, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–200 of 200 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1043251598?year=2019&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

200 matching records · $46,239.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 200 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 200.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $8.1404/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697821071 CMS
Lilly USA, LLC $6.7304/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657852049 CMS
Amgen Inc. $25.0004/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391051 CMS
Teva Pharmaceuticals USA, Inc. $10.7004/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697698021 CMS
Teva Pharmaceuticals USA, Inc. $8.7004/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697809487 CMS
Teva Pharmaceuticals USA, Inc. $4.9904/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697826309 CMS
Novartis Pharmaceuticals Corporation $10.6304/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836487 CMS
Teva Pharmaceuticals USA, Inc. $8.7004/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697771209 CMS
Upsher-Smith Laboratories LLC $20.2104/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679934867 CMS
Promius Pharma LLC $28.0203/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701092367 CMS
Teva Pharmaceuticals USA, Inc. $3.2503/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697696427 CMS
Teva Pharmaceuticals USA, Inc. $20.3003/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697695757 CMS
Amgen Inc. $4.0003/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391047 CMS
Lilly USA, LLC $15.4703/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657865827 CMS
Novartis Pharmaceuticals Corporation $4.5403/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836485 CMS
Teva Pharmaceuticals USA, Inc. $9.5903/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697695737 CMS
Teva Pharmaceuticals USA, Inc. $11.7903/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697697927 CMS
Amgen Inc. $23.9403/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391043 CMS
Novartis Pharmaceuticals Corporation $4.7303/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836483 CMS
Teva Pharmaceuticals USA, Inc. $9.5903/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697695723 CMS
ASSERTIO THERAPEUTICS, Inc. $18.2803/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681441227 CMS
Allergan Inc. $3.5603/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670771087 CMS
Lilly USA, LLC $88.8603/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657855555 CMS
Teva Pharmaceuticals USA, Inc. $17.1903/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697792733 CMS
Allergan Inc. $76.3703/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670771085 CMS
Amneal Pharmaceuticals LLC $25.3502/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692319349 CMS
Teva Pharmaceuticals USA, Inc. $9.5902/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697786917 CMS
Upsher-Smith Laboratories LLC $19.9002/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679934847 CMS
Amgen Inc. $21.7602/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391039 CMS
Teva Pharmaceuticals USA, Inc. $8.8802/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697770229 CMS
Teva Pharmaceuticals USA, Inc. $5.6502/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697765189 CMS
Novartis Pharmaceuticals Corporation $21.9302/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836499 CMS
Promius Pharma LLC $11.4902/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701092341 CMS
Teva Pharmaceuticals USA, Inc. $17.6402/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697819573 CMS
Teva Pharmaceuticals USA, Inc. $2.4302/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697841285 CMS
Amgen Inc. $17.5702/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391033 CMS
Lilly USA, LLC $4.8802/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657848661 CMS
Teva Pharmaceuticals USA, Inc. $14.6901/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697681341 CMS
Novartis Pharmaceuticals Corporation $22.5401/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836497 CMS
Teva Pharmaceuticals USA, Inc. $9.2101/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697770503 CMS
Teva Pharmaceuticals USA, Inc. $1.6201/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697679629 CMS
Teva Pharmaceuticals USA, Inc. $21.1601/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697830567 CMS
Allergan Inc. $17.7801/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670771081 CMS
Amgen Inc. $23.9401/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662391037 CMS
Teva Pharmaceuticals USA, Inc. $7.1501/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697764869 CMS
Teva Pharmaceuticals USA, Inc. $16.9401/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697813253 CMS
Amneal Pharmaceuticals LLC $17.9401/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692319347 CMS
Lilly USA, LLC $18.9501/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657865825 CMS
Teva Pharmaceuticals USA, Inc. $9.1801/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697845943 CMS
Novartis Pharmaceuticals Corporation $21.7601/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659836501 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $46,239.13 200
PY2020 $54,393.49 204
PY2021 $27,398.05 214
PY2022 $30,680.89 179
PY2023 $8,249.47 145
PY2024 $8,862.10 141
PY2025 $7,276.94 148

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $8,975.50 18
PY2024 Principal investigator $1,172.21 2
PY2023 Principal investigator $1,899.00 2
PY2022 Recipient $297.00 1
PY2022 Principal investigator $4,544.00 5
PY2021 Recipient $5,801.50 2
PY2021 Principal investigator $56,471.34 12
PY2020 Recipient $761.85 2
PY2020 Principal investigator $38,576.33 12
PY2019 Principal investigator $53,064.77 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $6,450.00 09/24/2025 Non-covered Recipient Entity
NERHC Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY WITH AN OPENLABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE No dispute reported 06/30/2026 1228771101
Principal investigator 1 Ipsen Innovation $77.00 07/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287718
Principal investigator 1 Ipsen Innovation $77.00 07/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287720
Principal investigator 1 Ipsen Innovation $77.00 07/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287722
Principal investigator 1 Ipsen Innovation $68.90 04/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants No dispute reported 06/30/2026 1184287708
Principal investigator 1 Ipsen Innovation $68.90 04/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287710
Principal investigator 1 Ipsen Innovation $68.90 04/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287712
Principal investigator 1 Ipsen Innovation $68.90 04/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants No dispute reported 06/30/2026 1184287714
Principal investigator 1 Ipsen Innovation $68.90 04/28/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287716
Principal investigator 1 Ipsen Innovation $180.00 02/20/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants No dispute reported 06/30/2026 1184287696
Principal investigator 1 Ipsen Innovation $300.00 02/20/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants No dispute reported 06/30/2026 1184287698
Principal investigator 1 Ipsen Innovation $300.00 02/20/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Episodic Migraine in Adult Participants No dispute reported 06/30/2026 1184287700
Principal investigator 1 Ipsen Innovation $150.00 02/18/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287702
Principal investigator 1 Ipsen Innovation $90.00 02/18/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287704
Principal investigator 1 Ipsen Innovation $150.00 02/18/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287706
Principal investigator 1 Ipsen Innovation $300.00 01/27/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287690
Principal investigator 1 Ipsen Innovation $180.00 01/27/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287692
Principal investigator 1 Ipsen Innovation $300.00 01/27/2025 Non-covered Recipient Entity
New England Regional Headache Center, Inc
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184287694